...
首页> 外文期刊>International Journal of Pharmaceutics >Divalent toxoids loaded stable chitosan-glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral administration
【24h】

Divalent toxoids loaded stable chitosan-glucomannan nanoassemblies for efficient systemic, mucosal and cellular immunostimulatory response following oral administration

机译:二价类毒素载有稳定的壳聚糖-葡甘露聚糖纳米组件,可在口服后有效地进行全身,黏膜和细胞的免疫刺激反应

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The present study reports dual tetanus and diphtheria toxoids loaded stable chitosan-glucomannan nanoassemblies (sCh-GM-NAs) formulated using tandem ionic gelation technique for oral mucosal immunization. The stable, lyophilized sCh-GM-NAs exhibited similar to 152 nm particle size and similar to 85% EE of both the toxoids. The lyophilized sCh-GM-NAs displayed excellent stability in biomimetic media and preserved chemical, conformation and biological stability of encapsulated toxoids. The higher intracellular APCs uptake of sCh-GM-NAs was concentration and time dependent which may be attributed to the receptor mediated endocytosis via mannose and glucose receptor. The higher Caco-2 uptake of sCh-GM-NAs was further confirmed by ex vivo intestinal uptake studies. The in vivo evaluation revealed that sCh-GM-NAs posed significantly (p < 0.001) higher humoral, mucosal and cellular immune response than other counterparts by eliciting complete protective levels of anti-TT and anti-DT (similar to 0.1 IU/mL) antibodies. Importantly, commercial 'Dual antigen' vaccine administered through oral or intramuscular route was unable to elicit all type of immune response. Conclusively, sCh-GM-NAs could be considered as promising vaccine adjuvant for oral mucosal immunization. (C) 2015 Elsevier B.V. All rights reserved.
机译:本研究报告了破伤风和白喉类毒素装载稳定的壳聚糖-葡甘露聚糖纳米组件(sCh-GM-NAs),采用串联离子凝胶技术配制,用于口腔粘膜免疫。稳定的,冻干的sCh-GM-NAs的类毒素表现出与152 nm相似的粒径和EE的85%的相似性。冻干的sCh-GM-NAs在仿生培养基中显示出极好的稳定性,并保留了包封的类毒素的化学,构象和生物学稳定性。 sCh-GM-NAs的较高的细胞内APC吸收是浓度和时间依赖性的,这可能归因于受体通过甘露糖和葡萄糖受体介导的内吞作用。 sCh-GM-NAs的较高的Caco-2摄取量通过离体肠道摄取研究得到进一步证实。体内评估表明,sCh-GM-NAs通过引发完整的抗TT和抗DT保护水平(约0.1 IU / mL),比其他同类药物显着(p <0.001)更高的体液,粘膜和细胞免疫应答。抗体。重要的是,通过口服或肌内途径施用的商业“双抗原”疫苗无法引发所有类型的免疫反应。结论是,sCh-GM-NAs可以被认为是用于口腔粘膜免疫的有希望的疫苗佐剂。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号